Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7658046 | 0.90 | EDNRA (0.59) | EDNRAEDNRB | |
| SCHEMBL7658049 | 0.90 | EDNRA (0.59) | EDNRAEDNRB | |
| SCHEMBL7567310 | 0.85 | MAOB (0.55) | EDNRAEDNRB | |
| SCHEMBL7533871 | 0.79 | MAOB (0.51) | EDNRAEDNRB | |
| SCHEMBL8204578 | 0.78 | EDNRA (0.84) | EDNRAEDNRB | |
| SCHEMBL7534548 | 0.77 | EDNRA (0.79) | EDNRAEDNRB | |
| SCHEMBL8204688 | 0.77 | EDNRA (0.79) | EDNRAEDNRB | |
| SCHEMBL8207340 | 0.77 | EDNRA (0.45) | EDNRAEDNRB | |
| SCHEMBL7945194 | 0.77 | EDNRA (0.77) | EDNRAEDNRB | |
| SCHEMBL7660780 | 0.76 | EDNRA (0.53) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0699069-B9 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-10-22 | — | — | EP | disclosed |
| US-6355813-B1 | INTERMEDIATES USEFUL IN PREPARING THESE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION | 2002-03-12 | — | — | US | disclosed |
| EP-0699069-B1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2002-02-13 | — | — | EP | disclosed |
| EP-0612244-B1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2001-09-19 | — | — | EP | disclosed |
| EP-1019397-A4 | A PROCESS OF MAKING 3-PHENYL-1-METHYLENEDIOXYPHENYL-INDANE-2-CARBOXYLIC ACID DERIVATIVES | SMITHKLINE BEECHAM CORP (US) | 2001-01-17 | — | — | EP | disclosed |
| US-6143907-A | 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives | SMITHKLINE BEECHAM CORPORATION (US) | 2000-11-07 | — | — | US | disclosed |
| EP-1019397-A1 | A PROCESS OF MAKING 3-PHENYL-1-METHYLENEDIOXYPHENYL-INDANE-2-CARBOXYLIC ACID DERIVATIVES | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-19 | — | — | EP | disclosed |
| US-6087389-A | TREATING CARDIOVASCULAR AND RENAL DISEASES INCLUDING HYPERTENSION, ACUTE AND CHRONIC RENAL FAILURE, CYCLOSPORINE INDUCED NEPHROTOXICITY, STROKE, CEREBROVASCULAR VASOSPASM, MYOCARDIAL ISCHEMIA, ANGINA, HEART FAILURE, ATHEROSCLEROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-11 | — | — | US | disclosed |
| US-5719183-A | HYPOTENSIVE AGENTS; KIDNEY DISEASES; ANTIISCHEMIC AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1997017341-A1 | A PROCESS OF MAKING 3-PHENYL-1-METHYLENEDIOXYPHENYL-INDANE-2-CARBOXYLIC ACID DERIVATIVES | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-15 | — | — | WO | disclosed |